Table 1.
Characteristics of directors on publicly traded healthcare companies boards, overall and by sector
| Characteristics | All healthcare companies (n=442) | Pharmaceutical (n=166) | Biotechnology (n=107) | Medical equipment and supply (n=94) | Healthcare provider (n=75) |
|---|---|---|---|---|---|
| Directorships (No) | 3434 | 1290 | 762 | 746 | 636 |
| Directorships held by individuals with academic affiliation* (%) | 309 (9.1) | 129 (10.0) | 63 (8.3) | 60 (8.0) | 57 (9.0) |
| Directorships held by individuals with clinical training and academic affiliation (%): | 167 (4.9) | 66 (5.1) | 34 (4.5) | 32 (4.3) | 35 (5.5) |
| Medical specialty | 79 (47.3) | 43 | 17 | 10 | 9 |
| Surgical specialty | 29 (17.4) | 10 | 3 | 9 | 7 |
| General medicine | 21 (12.6) | 6 | 3 | 4 | 8 |
| Pathology or radiology | 11 (6.6) | 2 | 5 | 3 | 1 |
| Pediatrics | 8 (4.8) | 1 | 2 | 1 | 4 |
| Obstetrics and gynecology | 7 (4.2) | 2 | 1 | 3 | 1 |
| Psychiatry | 3 (1.8) | 0 | 1 | 0 | 2 |
| Other graduate clinical training | 8 (4.8) | 1 | 2 | 2 | 3 |
| Graduate medical training not available | 1 (0.6) | 1 | 0 | 0 | 0 |
| Current academic appointment†: | |||||
| Clinical department | 88 (52.3) | 37 | 21 | 19 | 11 |
| Executive administration | 45 (27.0) | 14 | 6 | 9 | 16 |
| Preclinical department | 25 (15.0) | 11 | 6 | 4 | 4 |
| Academic trustee | 9 (5.4) | 4 | 1 | 0 | 4 |
*Individuals who held directorships at multiple companies were counted separately for each directorship.
†For the 167 clinically trained directors at the time of definitive proxy statement disclosure.